nivolumab,bempegaldesleukin
bms,nektar
['nivo', 'aldesleukin', 'bempeg', 'nivolumab', 'renal,(-adrenal)']
icymi - bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the pivot-02 study #esmo22 
#JITC is the official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. Editor-in-Chief: Pedro J. Romero, MD.